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BRIEF REPORT
Clonal Trisomy 11 in a Child With Acute Leukemia:
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Translocations involving the MLL gene located at
11q23 have been reported in acute lymphoblastic
leukemia (ALL), in 5±10% of cases with acute myeloid
leukemia (AML), frequently of the monocytic type, and
in biphenotypic leukemias expressing early stem cell as
well as both myeloid and lymphoid markers. MLL gene
rearrangement is the most common cytogenetic abnorm-
ality in infant leukemias and it can occur in therapy-
related leukemias as well.
Trisomy 11 is the fourth most common acquired
trisomy, occurring in 1% of AML/MDS cases [1].
Leukemias with trisomy 11 tend to express CD34,
HLA-DR, myeloid antigens CD15, CD13 or CD33, and
occasionally CD19. These leukemias are associated with
a poor prognosis similar to cases with MLL gene
rearrangements [1]. Recently, Schnittger et al. [2], in
their study of 387 patients, reported the partial tandem
duplication of the MLL gene, leading to the fusion of the
proto-oncogene with itself, in 5.7% of AML patients with
normal karyotypes, in 37.5% of cases with trisomy 11
with other cytogenetic abnormalities, and in 79% of cases
with trisomy 11 as the sole karyotypic abnormality.
Patients with this duplication had varying FAB morpho-
logies and a poor outcome. In addition to their possible
contribution to malignant transformation individually, the
high incidence of partial tandem duplication of the MLL
gene in cases with trisomy 11 suggests a link between
these two cytogenetic events. Our experience with a
13-year-old south Asian girl is relevant. She had bipheno-
typic leukemia and at relapse, was found to have trisomy
11 detected by FISH, but not by conventional G banding.
She presented with pancytopenia in December 1998.
Family history was signi®cant for several cancers (liver,
lung, colon, and brain) among close family members. A
maternal aunt with Fanconi anemia developed AML at
5 years of age. Physical examination of the patient was
not suggestive of Fanconi anemia and her diepoxybutane
(DEB)-induced chromosomal breakage studies performed
at the time of relapse were negative. At diagnosis, the
patient's bone marrow aspirate revealed blasts of
predominant L1 morphology; other blasts were large
with prominent nuclei. The blasts were strongly positive
for CD10, HLA-DR, CD19, CD22, CD34 and showed
milder expression of myeloid markers CD15 and CD13.
Cytochemical staining revealed the blasts to be positive
with Sudan black and 3±5% also were positive with
peroxidase. Conventional G banding revealed a small
number of metaphase cells that were 46 XX. A FISH
study for the MLL gene revealed two probe signals in
both metaphase and interphase. The patient had a
good response to a high risk ALL protocol that included
high-dose methotrexate, cytarabine, anthracyclines, and
teniposide. After 17 months of treatment, while on main-
tenance therapy, the leukemia relapsed in the bone
marrow. Analysis of relapse blasts had similar surface
markers but had lost CD34 and Sudan black positivity.
The blasts showed no clonal Ig-H variable region
rearrangements at that time. Again, conventional cyto-
genetic analysis showed a normal karyotype; however,
FISH study using LSI MLL (11q23) dual color DNA
probe (5 0 MLL spectrumgreen 3 0 MLL spectrumorange)
(Vysis Inc., Downers Grove, IL) revealed three sets of
separate fused signals in 89 of 200 interphase cells (44%),
but not in any metaphase cells. The results suggested that
the non-dividing cells were most likely trisomic for
chromosome 11.
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DISCUSSION
There are several interesting points. Most of the
reported AML patients with trisomy 11 have been adults.
One child was included among the patients reported by
Schnittger et al. That child with secondary AML had
partial tandem duplication of the MLL gene without
trisomy 11 [2]. Trisomy 11 appears to be a rare abnor-
mality in pediatric cases. In a recently reported series of
478 children with AML, one had trisomy 11 as the sole
cytogenetic abnormality and four others had it as part of
an abnormal cytogenetic complex [3]. Our case repre-
sents a biphenotypic leukemia with Sudan black posi-
tivity and strong expression of B-lineage surface markers
at diagnosis. At relapse, the leukemic clone revealed
neither Sudan black positivity nor any clonal Ig-H
variable region rearrangements.
The detection of trisomy 11 by FISH at relapse, but not
at diagnosis, can be explained by either dilution of the
trisomy 11 clone by karyotypically normal leukemic
clonal cells, or by the emergence of a new clone with
trisomy 11 at relapse as suggested by Slovak et al. [1].
Since our patient had received topoisomerase II inhibitors
as a part of initial therapy, there is also the possibility of
a secondary leukemia in her case. However, similarity
between morphologic and immunophenotypic characte-
ristics of the blasts at diagnosis and relapse are against
this possibility. If topoisomerase II inhibitors played a
role, detection of trisomy 11 could be explained by the
induction of secondary cytogenetic changes in the initial
leukemic clone. On the other hand, presence of the same
type of duplication fusion transcript of the MLL gene, at
both diagnosis and relapse reported in two cases of AML,
with additional karyotypic changes but without trisomy
11 during relapse, suggests that partial tandem dupli-
cation of MLL gene may be a primary event in leuko-
mogenesis [2]. We did not test our patient for this
mutation; it thus could be the case with her.
The detection of trisomy 11 in leukemic cells by FISH,
but not by conventional cytogenetics, is another fascinat-
ing aspect of this report. This is similar to detection of
t(15;17) by FISH but not by G banding in some patients
with acute promyelocytic leukemia [4]. In addition to the
possibility of the presence of two clones of leukemic
cells, three other mechanistic explanations for the detec-
tion of trisomy 11 by FISH (especially in interphase and
not in metaphase), but not by G banding are: (1) leukemic
cells with trisomy 11 giving rise to poor morphology
metaphases resulting in their eventual exclusion from the
analysis, as occurs in monosomy 7; (2) decreased proli-
feration of trisomy cells in the culture, with or without
dilution by non-malignant cells; and (3) slow growth rate
of trisomy 11 cells in vivo due to unknown intrinsic cell
cycle characteristics and/or the effect of recent main-
tenance chemotherapy [5,6].
The occurence of trisomy 11 cases without MLL gene
partial duplication, and the demonstration of duplication
in cases with normal karyotypes, hinders the determina-
tion of which abnormality precedes the other. FISH
analysis of the cases with partial tandem MLL gene
duplication without trisomy 11 by G banding may be of
interest and may contribute toward an understanding of
the temporal relationship between the MLL duplication
and trisomy 11. Finally, as suggested by Tanaka et al. [6],
the application of FISH in the search for speci®c genetic
abnormalities in selected cases may provide additional
useful information.
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